Intracellular calcium modulation of voltage-gated sodium channels in ventricular myocytes

Cardiovasc Res. 2009 Jan 1;81(1):72-81. doi: 10.1093/cvr/cvn274. Epub 2008 Oct 1.

Abstract

Aims: Cardiac voltage-gated sodium channels control action potential (AP) upstroke and cell excitability. Intracellular calcium (Ca(i)(2+)) regulates AP properties by modulating various ion channels. Whether Ca(i)(2+) modulates sodium channels in ventricular myocytes is unresolved. We studied whether Ca(i)(2+) modulates sodium channels in ventricular myocytes at Ca(i)(2+) concentrations ([Ca(i)(2+)]) present during the cardiac AP (0-500 nM), and how this modulation affects sodium channel properties in heart failure (HF), a condition in which Ca(i)(2+) homeostasis is disturbed.

Methods and results: Sodium current (I(Na)) and maximal AP upstroke velocity (dV/dt(max)), a measure of I(Na), were studied at 20 and 37 degrees C, respectively, in freshly isolated left ventricular myocytes of control and HF rabbits, using whole-cell patch-clamp methodology. [Ca(i)(2+)] was varied using different pipette solutions, the Ca(i)(2+) buffer BAPTA, and caffeine administration. Elevated [Ca(i)(2+)] reduced I(Na) density and dV/dt(max), but caused no I(Na) gating changes. Reductions in I(Na) density occurred simultaneously with increase in [Ca(i)(2+)], suggesting that these effects were due to permeation block. Accordingly, unitary sodium current amplitudes were reduced at higher [Ca(i)(2+)]. While I(Na) density and gating at fixed [Ca(i)(2+)] were not different between HF and control, reductions in dV/dt(max) upon increases in stimulation rate were larger in HF than in control; these differences were abolished by BAPTA.

Conclusion: Ca(i)(2+) exerts acute modulation of I(Na) density in ventricular myocytes, but does not modify I(Na) gating. These effects, occurring rapidly and in the [Ca(i)(2+)] range observed physiologically, may contribute to beat-to-beat regulation of cardiac excitability in health and disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Action Potentials / physiology
  • Animals
  • Buffers
  • Caffeine / pharmacology
  • Calcium / metabolism*
  • Calcium / pharmacology
  • Cell Line
  • Cells, Cultured
  • Disease Models, Animal
  • Egtazic Acid / analogs & derivatives
  • Egtazic Acid / pharmacology
  • Heart Failure / metabolism
  • Heart Failure / pathology
  • Heart Failure / physiopathology
  • Heart Rate / drug effects
  • Heart Rate / physiology
  • Heart Ventricles / cytology*
  • Heart Ventricles / metabolism*
  • Homeostasis
  • Humans
  • Muscle Proteins / genetics
  • Muscle Proteins / metabolism
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism*
  • NAV1.5 Voltage-Gated Sodium Channel
  • Patch-Clamp Techniques
  • Phosphodiesterase Inhibitors / pharmacology
  • Rabbits
  • Sodium Channels / genetics
  • Sodium Channels / metabolism*
  • Transfection

Substances

  • Buffers
  • Muscle Proteins
  • NAV1.5 Voltage-Gated Sodium Channel
  • Phosphodiesterase Inhibitors
  • SCN5A protein, human
  • Sodium Channels
  • Caffeine
  • Egtazic Acid
  • 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid
  • Calcium